PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS ανά Francis, G, Hughes, R, King, J, Mitchell, P, Joubert, J, McLeod, J, Parker, G, Pollard, J, Sindic, C, Duprez, T, Medaer, R, Broeckx, J, Vanroose, E, Carton, H, Wilms, G, Rice, G, Ebers, G, Lee, D, Freedman, M, Nelson, R, Rabinovitch, H, Christie, S, Avruch, L, Oger, J, Paty, D

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis ανά Ebers, G, Oger, J, Paty, D, Li, D, Freedman, M, Hartung, H, Hommes, O, McLeod, J, Sandberg, M, Wikstrom, J, Carton, H, Hughes, R, Pancelius, M, Medaer, R, Blumhardt, L, Barnes, D, Bertelsmann, F, Chofflon, M, Kappos, L, King, J, Newsom-Davis, J, Sindic, C, Uitehaag, B, Van Doom, P, Bates, D